Business Description
EPS Creative Health Technology Group Ltd
ISIN : KYG3121P1054
Total Employee Number:
133Compare
Compare
Traded in other countries / regions
03860.Hong Kong IPO Date
2017-02-08Description
EPS Creative Health Technology Group Ltd is an investment holding company. The Company operates in the Garment Business, Healthcare Products Business, and IRO with CRO and In-House R&D Business segments. The Garment Business includes the sales of apparel products and the provision of apparel supply chain management services. The Healthcare Products Business includes the trading of healthcare and medicated products and the leasing of medical devices and generates the maximum revenue. The IRO with CRO and In-House R&D Business includes the provision of IRO and CRO services and in-house R&D. The Company derives a majority of its revenue from the PRC and also has a presence in Hong Kong, Japan, Europe, the United States and other countries.
Financial Strength
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 28.42 | |||||
Equity-to-Asset | 0.34 | |||||
Debt-to-Equity | 0.04 | |||||
Debt-to-EBITDA | 0.28 | |||||
Interest Coverage | 0.12 | |||||
Piotroski F-Score | 3/9 | |||||
Altman Z-Score | 3.08 | |||||
Beneish M-Score | -3.56 | |||||
WACC vs ROIC | ||||||
Growth Rank
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | -1.1 | |||||
3-Year EPS without NRI Growth Rate | 35 | |||||
3-Year Book Growth Rate | 5.1 |
Momentum Rank
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 70.12 | |||||
9-Day RSI | 63.52 | |||||
14-Day RSI | 59.69 | |||||
3-1 Month Momentum % | -1.72 | |||||
6-1 Month Momentum % | -9.52 | |||||
12-1 Month Momentum % | 18.75 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 1.83 | |||||
Quick Ratio | 1.59 | |||||
Cash Ratio | 1.09 | |||||
Days Inventory | 24.47 | |||||
Days Sales Outstanding | 58.6 | |||||
Days Payable | 27.09 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Dividend Yield % | 1.64 | |||||
5-Year Yield-on-Cost % | 1.71 | |||||
3-Year Average Share Buyback Ratio | -1.5 | |||||
Shareholder Yield % | 3 |
Profitability Rank
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 16.39 | |||||
Operating Margin % | 0.17 | |||||
Net Margin % | -3.03 | |||||
EBITDA Margin % | 3.45 | |||||
FCF Margin % | 5.49 | |||||
OCF Margin % | 6.16 | |||||
ROE % | -12.23 | |||||
ROA % | -4.16 | |||||
ROIC % | 0.56 | |||||
3-Year ROIIC % | 42.55 | |||||
ROC (Joel Greenblatt) % | -7.02 | |||||
ROCE % | -0.52 | |||||
Years of Profitability over Past 10-Year | 6 |
GF Value Rank
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Price-to-Owner-Earnings | 14.64 | |||||
PS Ratio | 0.71 | |||||
PB Ratio | 3.15 | |||||
Price-to-Tangible-Book | 21 | |||||
Price-to-Free-Cash-Flow | 13.13 | |||||
Price-to-Operating-Cash-Flow | 11.67 | |||||
EV-to-EBIT | -247.18 | |||||
EV-to-EBITDA | 16.82 | |||||
EV-to-Revenue | 0.58 | |||||
EV-to-FCF | 10.57 | |||||
Price-to-GF-Value | 1.07 | |||||
Price-to-Projected-FCF | 63 | |||||
| Price-to-Net-Current-Asset-Value | 63 | |||||
Earnings Yield (Greenblatt) % | -0.4 | |||||
FCF Yield % | 6.84 | |||||
Forward Rate of Return (Yacktman) % | 3.24 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
EPS Creative Health Technology Group Ltd Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil HK$) | 457.646 | ||
| EPS (TTM) (HK$) | -0.027 | ||
| Beta | -0.3327 | ||
| 3-Year Sharpe Ratio | -0.21 | ||
| 3-Year Sortino Ratio | -0.33 | ||
| Volatility % | 55.84 | ||
| 14-Day RSI | 59.69 | ||
| 14-Day ATR (HK$) | 0.034755 | ||
| 20-Day SMA (HK$) | 0.57325 | ||
| 12-1 Month Momentum % | 18.75 | ||
| 52-Week Range (HK$) | 0.455 - 0.84 | ||
| Shares Outstanding (Mil) | 582.43 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 3 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
EPS Creative Health Technology Group Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
EPS Creative Health Technology Group Ltd Stock Events
| Event | Date | Price (HK$) | ||
|---|---|---|---|---|
| HKD 0.010000 Cash Dividend | 2025-08-20 | 0.51 (+0.00%) |
Show
Entries
EPS Creative Health Technology Group Ltd Frequently Asked Questions
What is EPS Creative Health Technology Group Ltd(HKSE:03860)'s stock price today?
The current price of HKSE:03860 is HK$0.63. The 52 week high of HKSE:03860 is HK$0.84 and 52 week low is HK$0.46.
When is next earnings date of EPS Creative Health Technology Group Ltd(HKSE:03860)?
The next earnings date of EPS Creative Health Technology Group Ltd(HKSE:03860) is .
Does EPS Creative Health Technology Group Ltd(HKSE:03860) pay dividends? If so, how much?
The Dividend Yield %  of EPS Creative Health Technology Group Ltd(HKSE:03860) is 1.64% (As of Today), Highest Dividend Payout Ratio of EPS Creative Health Technology Group Ltd(HKSE:03860) was 0.36. The lowest was 0.28. And the median was 0.32. The  Forward Dividend Yield % of EPS Creative Health Technology Group Ltd(HKSE:03860) is 0%. For more information regarding to dividend, please check our Dividend Page.
Press Release
| Subject | Date | ||
|---|---|---|---|
| Healthcare Demand Upgrade, EPS Creative Health Technology Group (3860.HK) Expands Its Healthcare Business | 2026-07-24 |
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers